| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |